Clinical Trial Update: A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 single-dose study of PF-04620110 in overweight/obese, otherwise healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• PF-04620110

Snippet

Sponsor: Pfizer | Conditions: Overweight | Phase 1 | Status: COMPLETED